CRGO(CRGO)
CRGO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $31M | $35M | $41M | $73M |
| Low | $30M | $34M | $40M | $72M |
| High | $31M | $35M | $41M | $73M |
| EBITDA Avg | $-26M | $-29M | $-34M | $-62M |
| Low | $-26M | $-30M | $-35M | $-62M |
| High | $-26M | $-29M | $-34M | $-61M |
| EBIT Avg | $-28M | $-31M | $-36M | $-66M |
| Low | $-28M | $-31M | $-37M | $-66M |
| High | $-27M | $-31M | $-36M | $-65M |
| Net Income Avg | $-12M | $-3M | $3M | $1M |
| Low | $-13M | $-3M | $3M | $1M |
| High | $-12M | $-3M | $3M | $1M |
| EPS Avg | $-0.24 | $-0.05 | $0.06 | $0.02 |
| Low | $-0.25 | $-0.05 | $0.06 | $0.02 |
| High | $-0.24 | $-0.05 | $0.06 | $0.02 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $8M | $8M | $8M | $8M | $9M | $9M |
| Low | $8M | $8M | $8M | $8M | $8M | $8M |
| High | $8M | $9M | $8M | $9M | $9M | $9M |
| EBITDA Avg | $-7M | $-7M | $-7M | $-7M | $-7M | $-7M |
| Low | $-7M | $-7M | $-7M | $-7M | $-7M | $-8M |
| High | $-6M | $-7M | $-7M | $-7M | $-7M | $-7M |
| EBIT Avg | $-7M | $-8M | $-7M | $-8M | $-8M | $-8M |
| Low | $-7M | $-8M | $-8M | $-8M | $-8M | $-8M |
| High | $-7M | $-7M | $-7M | $-7M | $-8M | $-8M |
| Net Income Avg | $-2M | $-1M | $-772,912 | $-2M | $-1M | $-1M |
| Low | $-2M | $-1M | $-796,127 | $-2M | $-1M | $-1M |
| High | $-2M | $-999,596 | $-749,697 | $-1M | $-999,596 | $-999,596 |
| EPS Avg | $-0.04 | $-0.02 | $-0.01 | $-0.03 | $-0.02 | $-0.02 |
| Low | $-0.05 | $-0.02 | $-0.02 | $-0.03 | $-0.02 | $-0.02 |
| High | $-0.04 | $-0.02 | $-0.01 | $-0.03 | $-0.02 | $-0.02 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |